• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Biomedical Textiles Market

    ID: MRFR/CnM/4621-HCR
    100 Pages
    Priya Nagrale
    October 2025

    Biomedical Textiles Market Research Report Information By Fiber Type (Non-Biodegradable, Biodegradable), Fabric Type (Woven, Non-Woven), Product Type (Non-Implantable, Implantable), Applications (Dentistry, General Surgery & Treatment), Region – Forecast Till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Biomedical Textiles Market Infographic
    Purchase Options

    Biomedical Textiles Market Summary

    The Global Biomedical Textiles Market is projected to grow from 18.72 USD Billion in 2024 to 37.12 USD Billion by 2035, reflecting a robust growth trajectory.

    Key Market Trends & Highlights

    Biomedical Textiles Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 6.26 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 36.5 USD Billion, indicating substantial growth opportunities.
    • in 2024, the market is valued at 18.72 USD Billion, highlighting its current significance in the biomedical sector.
    • Growing adoption of advanced textile technologies due to increasing demand for innovative medical solutions is a major market driver.

    Market Size & Forecast

    2024 Market Size 18.72 (USD Billion)
    2035 Market Size 37.12 (USD Billion)
    CAGR (2025-2035) 6.42%

    Major Players

    Secant Group, LLC, Confluent Medical Technologies, SWICOFIL AG, Johnson & Johnson Services, Inc., Meister & Cie AG, Cardinal Health, Smith & Nephew, Medline Industries, Inc, Integra LifeSciences Corporation, PAUL HARTMANN AG, BSN medical, B. Braun Melsungen AG, 3M, Elkem Silicones, ATEX TECHNOLOGIES

    Biomedical Textiles Market Drivers

    Surge in Surgical Procedures

    A surge in surgical procedures globally is contributing to the expansion of the Global Biomedical Textiles Market Industry. With advancements in minimally invasive techniques and an increase in elective surgeries, there is a heightened demand for surgical textiles, including sutures, meshes, and drapes. These textiles are essential for ensuring patient safety and promoting effective recovery. The market's growth is further supported by the rising awareness of the importance of high-quality surgical materials. As surgical volumes continue to rise, the Global Biomedical Textiles Market Industry is expected to witness substantial growth, driven by the need for innovative and reliable textile solutions in surgical settings.

    Market Trends and Projections

    The Global Biomedical Textiles Market Industry is poised for substantial growth, with projections indicating a market value of 18.7 USD Billion in 2024 and an anticipated increase to 36.5 USD Billion by 2035. The expected CAGR of 6.26% from 2025 to 2035 highlights the ongoing evolution of this sector. Key trends influencing this growth include technological advancements, increasing healthcare expenditures, and a rising focus on personalized medicine. As the industry adapts to these trends, it is likely to witness the emergence of new applications and innovations, further solidifying its position in the global healthcare landscape.

    Increasing Geriatric Population

    The increasing geriatric population is a significant driver of the Global Biomedical Textiles Market Industry. As individuals age, they often experience a higher incidence of chronic diseases and conditions that necessitate specialized medical textiles for effective management. This demographic shift is prompting healthcare systems to invest in advanced biomedical textiles, such as compression garments and orthopedic supports, to enhance the quality of life for elderly patients. The growing awareness of the benefits of these products is likely to bolster market growth. Consequently, the Global Biomedical Textiles Market Industry is positioned to benefit from the rising demand for tailored solutions catering to the unique needs of the aging population.

    Growing Focus on Infection Control

    The growing focus on infection control within healthcare settings is a crucial driver of the Global Biomedical Textiles Market Industry. Healthcare providers are increasingly adopting antimicrobial textiles to reduce the risk of hospital-acquired infections. These textiles are utilized in various applications, including surgical gowns, drapes, and wound dressings. The heightened awareness of infection prevention strategies is likely to propel demand for advanced biomedical textiles that offer enhanced protection. As healthcare systems prioritize patient safety, the Global Biomedical Textiles Market Industry is expected to expand, reflecting the increasing reliance on innovative textile solutions to combat infections.

    Rising Demand for Advanced Wound Care Solutions

    The Global Biomedical Textiles Market Industry experiences a surge in demand for advanced wound care solutions, driven by an increasing prevalence of chronic wounds and surgical procedures. Innovative textile materials, such as hydrogels and nanofibers, are being developed to enhance healing processes. For instance, the market is projected to reach 18.7 USD Billion in 2024, reflecting a growing recognition of the importance of effective wound management. The integration of antimicrobial properties into textiles further supports this trend, as healthcare providers seek to minimize infection risks. This growing demand for specialized wound care products is expected to significantly contribute to the overall growth of the Global Biomedical Textiles Market Industry.

    Technological Advancements in Textile Engineering

    Technological advancements in textile engineering play a pivotal role in shaping the Global Biomedical Textiles Market Industry. Innovations such as 3D printing and smart textiles are revolutionizing the production of biomedical textiles, allowing for customized solutions tailored to individual patient needs. These advancements not only enhance the functionality of biomedical textiles but also improve their biocompatibility and performance. As a result, the market is anticipated to grow at a CAGR of 6.26% from 2025 to 2035, potentially reaching 36.5 USD Billion by 2035. The continuous evolution of textile technologies is likely to drive the development of new applications, further expanding the scope of the Global Biomedical Textiles Market Industry.

    Key Companies in the Biomedical Textiles Market market include

    Industry Developments

    • Q2 2024: Confluent Medical Technologies Announces Expansion of Biomedical Textile Manufacturing Facility in Costa Rica Confluent Medical Technologies opened a new, expanded biomedical textile manufacturing facility in Costa Rica to increase production capacity for implantable medical textiles used in cardiovascular and orthopedic devices.
    • Q1 2024: Secant Group Launches Regenerez™ Bioabsorbable Textile Platform for Regenerative Medicine Secant Group introduced Regenerez™, a new bioabsorbable textile platform designed for use in regenerative medicine applications, expanding its biomedical textile product portfolio.
    • Q2 2024: DSM Biomedical and Terumo Aortic Announce Strategic Partnership for Textile-Based Vascular Grafts DSM Biomedical entered a strategic partnership with Terumo Aortic to co-develop advanced textile-based vascular grafts, leveraging DSM’s biomedical textile technology for next-generation cardiovascular implants.
    • Q3 2024: Poly-Med, Inc. Receives FDA 510(k) Clearance for Biofelt™ Absorbable Textile Scaffold Poly-Med, Inc. received FDA 510(k) clearance for its Biofelt™ absorbable textile scaffold, enabling commercialization of the product for soft tissue repair and regenerative medicine applications.
    • Q2 2024: Freudenberg Medical Expands Biomedical Textile Production with New Facility in Massachusetts Freudenberg Medical opened a new manufacturing facility in Massachusetts dedicated to the production of biomedical textiles for implantable medical devices, aiming to meet growing demand in the U.S. market.
    • Q1 2025: Medtronic Acquires Textile-Based Hernia Mesh Startup Synovis for $150 Million Medtronic completed the acquisition of Synovis, a startup specializing in textile-based hernia mesh implants, to strengthen its surgical solutions portfolio.
    • Q2 2025: B. Braun Launches New Line of Antimicrobial Surgical Sutures Using Advanced Textile Technology B. Braun introduced a new line of antimicrobial surgical sutures made with advanced biomedical textile technology, targeting infection reduction in surgical procedures.
    • Q1 2024: Stryker Announces $100 Million Investment in Biomedical Textile R&D Center Stryker announced a $100 million investment to establish a new research and development center focused on biomedical textiles for orthopedic and soft tissue repair devices.
    • Q3 2024: Cardinal Health Signs Multi-Year Supply Agreement for Implantable Textile Mesh with Advanced Medical Solutions Cardinal Health entered a multi-year supply agreement with Advanced Medical Solutions to source implantable textile mesh for use in surgical and wound care products.
    • Q2 2025: Integra LifeSciences Receives CE Mark for New Textile-Based Dura Substitute Integra LifeSciences received CE Mark approval for its new textile-based dura substitute, allowing commercialization in the European Union for neurosurgical applications.
    • Q1 2025: Lydall Invests $50 Million in Expansion of Biomedical Textile Operations in North Carolina Lydall announced a $50 million investment to expand its biomedical textile manufacturing operations in North Carolina, increasing capacity for medical implant and wound care products.
    • Q2 2024: Avient Corporation Launches New Biocompatible Textile Fiber for Implantable Medical Devices Avient Corporation launched a new biocompatible textile fiber designed for use in implantable medical devices, expanding its offerings in the biomedical textiles sector.

    Intended Audience

      • Biomedical textiles manufacturers
      • Traders and distributors of biomedical textiles
      • Research and development institutes
      • Potential investors
      • Raw material suppliers
      • Nationalized laboratory

    Future Outlook

    Biomedical Textiles Market Future Outlook

    The Global Biomedical Textiles Market is projected to grow at a 6.42% CAGR from 2025 to 2035, driven by technological advancements, increasing healthcare demands, and rising awareness of wound care.

    New opportunities lie in:

    • Develop biodegradable textiles for sustainable medical applications.
    • Invest in smart textiles integrated with biosensors for real-time health monitoring.
    • Expand into emerging markets with tailored biomedical textile solutions.

    By 2035, the market is expected to exhibit robust growth, positioning itself as a leader in innovative healthcare solutions.

    Market Segmentation

    Market Segmentation

    Intended Audience
    • Biomedical textiles manufacturers
    • Traders and distributors of biomedical textiles
    • Research and development institutes
    • Potential investors
    • Raw material suppliers
    • Nationalized laboratory

    Report Scope

    Report Attribute/Metric Details
    Market Size 2024 USD 18.72 billion
    Market Size 2035 37.12
    Compound Annual Growth Rate (CAGR) 6.42% (2025 - 2035)
    Base Year 2024
    Forecast Period 2025 - 2035
    Historical Data 2019 & 2020
    Forecast Units Value (USD Billion)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Segments Covered fiber type, fabric type, product type and application
    Geographies Covered Asia Pacific, North America, Europe, Latin America, and the Middle East and Africa.
    Countries Covered The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
    Key Companies Profiled Secant Group, LLC (U.S.), Confluent Medical Technologies (U.S.), SWICOFIL AG (Switzerland), Johnson & Johnson Services, Inc. (U.S.), Meister & Cie AG (Switzerland), Cardinal Health. (U.S.), Smith & Nephew (UK), Medline Industries, Inc (India), Integra LifeSciences Corporation. (U.S.), PAUL HARTMANN AG (Germany), BSN medical. (Germany), B. Braun Melsungen AG (Germany), 3M (U.S.), Elkem Silicones (Norway), and ATEX TECHNOLOGIES (U.S.).
    Key Market Opportunities Huge market scope for biomedical textiles in the healthcare industry
    Key Market Dynamics Growing healthcare industry on account of rising healthcare budget, growing health awareness, and rising healthcare expenditure is likely to drive the global biomedical textiles industry
    Market Size 2025 19.92

    Market Highlights

    Author
    Priya Nagrale
    Senior Research Analyst

    With an experience of over five years in market research industry (Chemicals & Materials domain), I gather and analyze market data from diverse sources to produce results, which are then presented back to a client. Also, provide recommendations based on the findings. As a Senior Research Analyst, I perform quality checks (QC) for market estimations, QC for reports, and handle queries and work extensively on client customizations. Also, handle the responsibilities of client proposals, report planning, report finalization, and execution

    Leave a Comment

    FAQs

    What would primarily drive the biomedical textile market in the healthcare sector?

    Rising investment in the healthcare sector would ensure growth.

    What could deter the biomedical textile market growth?

    High expenditure for research and innovation and complex production procedure can deter the biomedical textile market growth.

    What are the applications of the biomedical textile market?

    The applications are neurology, ophthalmology, dentistry, cardiology, general surgery & treatment, orthopedics, and others.

    Name companies involved in making growth possible for the biomedical textile market.

    Companies like Confluent Medical Technologies (U.S.), Secant Group, LLC (U.S.), Meister & Cie AG (Switzerland), SWICOFIL AG (Switzerland), Johnson & Johnson Services, Inc. (U.S.), Medline Industries, Inc (India), Cardinal Health. (U.S.), Smith & Nephew (UK), BSN medical. (Germany), Integra LifeSciences Corporation. (U.S.), PAUL HARTMANN AG (Germany), Elkem Silicones (Norway), B. Braun Melsungen AG (Germany), 3M (U.S.), and ATEX TECHNOLOGIES (U.S.) would inspire growth.

    What strategies would inspire growth for the biomedical textile market?

    Mergers, collaboration, hike in investment for R&D, better market exposure, marketing strategy, innovation, product launch, and others would influence the biomedical textile market growth.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials